Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1324-2022

Drug recall · August 17, 2022

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator recall

Why: CGMP Deviations: products were stored outside the drug label specifications.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.

Quantity
1 box
Company
Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
Distribution
Nationwide in the USA.
Initiated
June 29, 2022 · Voluntary: Firm initiated
Classified
August 5, 2022
Reported
August 17, 2022
Ended
February 13, 2024
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.